David L Rogers, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Intravitreal ERT to Prevent Retinal Disease Progression in Children With CLN2 (NCT05152914) | David L Rogers, MD | 2021-11-01 |
Track David L Rogers, MD automatically
Every clearance here is in the API, with alerts when new ones post.